News of the Day

Former Medicines NZ chair says the time for talk on Pharmac is over December 5, 2023

A former chair of Medicines New Zealand has called on the country's new coalition government to act quickly on its plans to reform Pharmac.

Ex-TGA head John Skerritt appointed to Medicines Australia board December 5, 2023

Professor John Skerritt has joined the Medicines Australia board as an independent elected director after retiring from the Australian Public Service in April.

FDA confirms approach to Sofdra NDA resubmission and the materials required December 4, 2023

Clinical dermatology company Botanix Pharmaceuticals (ASX:BOT) has received feedback from the US FDA following its 'end of review' Type A meeting request with respect to the Sofdra new drug application review.

National Pharmacies opens its first 24-7 pharmacy under South Australian initiative December 4, 2023

South Australian Premier Peter Malinauskas said, “People get sick at any time of day and having prompt access to medication and trusted health advice is vital.”

PharmAust completes Phase 1 MEND study and files for US Orphan Drug Designation December 4, 2023

Clinical-stage biotechnology company PharmAust (ASX:PAA) has announced that all patients have completed its Phase 1 MEND Study of monepantel for motor neurone disease.

OncoSil Medical onboards first patient in the PANCOSIL clinical trial December 4, 2023

Australian medical device company OncoSil Medical (ASX:OSL) has announced that the first patient has been treated in the PANCOSIL Investigator-Initiated Clinical Trial.

Korean regulator approves Amplia Therapeutics' pancreatic cancer trial December 4, 2023

The Korean Ministry of Food and Drug Safety has approved Amplia Therapeutics' (ASX:ATX) clinical trial to test narmafotinib (AMP945) in combination with gemcitabine and abraxane in advanced pancreatic cancer patients.

Members Health welcomes federal government's stricter vaping laws December 4, 2023

Members Health has welcomed the Albanese Government's stricter enforcement of e-cigarette laws, which will see imports of disposable single-use vapes banned from 1 January.

Medibank and Healthscope annnounce a 'strengthened' partnership December 4, 2023

Medibank and Healthscope have announced a strengthened partnership that aims to drive innovation in patient care, outcomes and experience.

How does this indicate 'progress' on an 'action plan to enhance organisational culture'? December 4, 2023

New employees were not responsible for the emails that disgusted patients and the wider community. The chief executive has been a senior leader at Pharmac for over ten years and carries primary responsibility for the organisation's culture.

Company submissions request faster access for cancer immunotherapies December 4, 2023

The Pharmaceutical Benefits Advisory Committee will consider two submissions at its December intracycle meeting that could fundamentally reshape PBS policy and decision-making.

Is the system about to be seriously tested? Will it deliver? What will it deliver? December 4, 2023

Suppose the system can accommodate this proposal based on company submissions, PBAC advice and a ministerial policy decision. In that case, we should end the charade of a secret discussion about discount rates and comparator selection.

Latest Video

Most Read

Company submissions request faster access for cancer immunotherapies

AstraZeneca welcomes expanded PBS listing for its immunotherapy

How does this indicate 'progress' on an 'action plan to enhance organisational culture'?

Former Medicines NZ chair says the time for talk on Pharmac is over

Is the system about to be seriously tested? Will it deliver? What will it deliver?

New Stories

Former Medicines NZ chair says the time for talk on Pharmac is over

Ex-TGA head John Skerritt appointed to Medicines Australia board

FDA confirms approach to Sofdra NDA resubmission and the materials required

National Pharmacies opens its first 24-7 pharmacy under South Australian initiative

PharmAust completes Phase 1 MEND study and files for US Orphan Drug Designation

OncoSil Medical onboards first patient in the PANCOSIL clinical trial

Korean regulator approves Amplia Therapeutics' pancreatic cancer trial

Sign In

Latest Video

Most Read

Company submissions request faster access for cancer immunotherapies

AstraZeneca welcomes expanded PBS listing for its immunotherapy

How does this indicate 'progress' on an 'action plan to enhance organisational culture'?

Former Medicines NZ chair says the time for talk on Pharmac is over

Is the system about to be seriously tested? Will it deliver? What will it deliver?

Follow Us

New Stories

Former Medicines NZ chair says the time for talk on Pharmac is over

Ex-TGA head John Skerritt appointed to Medicines Australia board

FDA confirms approach to Sofdra NDA resubmission and the materials required

National Pharmacies opens its first 24-7 pharmacy under South Australian initiative

PharmAust completes Phase 1 MEND study and files for US Orphan Drug Designation

OncoSil Medical onboards first patient in the PANCOSIL clinical trial

Korean regulator approves Amplia Therapeutics' pancreatic cancer trial